We are live on ! Find out more
RC

RBF Capital Portfolio holdings

AUM $2.05B
1-Year Est. Return 29.64%
This Fund
S&P 500
This Quarter Est. Return
+11.78%
1 Year Est. Return
+29.64%
3 Year Est. Return
+141.07%
5 Year Est. Return
+189.1%
10 Year Est. Return
+995.66%
AUM
$2.1B
AUM Growth
+$437M
Cap. Flow
+$270M
Cap. Flow %
12.82%
Top 10 Hldgs %
26.48%
Holding
635
New
60
Increased
34
Reduced
85
Closed
33

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$99.5M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$83.6M
3
APP icon
Applovin
APP
+$37.3M
4
UNH icon
UnitedHealth
UNH
+$21M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.8M

Top Sells

Rank Stock Value
1
DESP
Despegar.com
DESP
+$8.85M
2
BERY
Berry Global Group, Inc.
BERY
+$6.99M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.52M
4
DFS
Discover Financial Services
DFS
+$2.82M
5
AMZN icon
Amazon
AMZN
+$2.57M

Sector Composition

Rank Sector Weight
1 Financials 29.3%
2 Industrials 12.65%
3 Consumer Discretionary 10.14%
4 Technology 9.47%
5 Communication Services 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMBT
551
CMB.TECH NV
CMBT
$4.57B
$144K 0.01%
15,955
– –
ACH
552
Accendra Health
ACH
$240M
$130K 0.01%
14,277
-10,623
-43% -$78.3K
KZR
553
DELISTED
Kezar Life Sciences
KZR
$129K 0.01%
28,253
– –
M icon
554
Macy's
M
$6.15B
$128K 0.01%
11,000
-3,000
-21% -$34.8K
ZURA icon
555
Zura Bio
ZURA
$497M
$126K 0.01%
+120,000
New +$143K
HDSN
556
Hudson Technologies
HDSN
$267M
$123K 0.01%
15,193
-22,509
-60% -$154K
HGBL icon
557
Heritage Global
HGBL
$41.7M
$121K 0.01%
54,283
– –
BZUN
558
Baozun
BZUN
$144M
$120K 0.01%
47,900
– –
DENN
559
DELISTED
Denny's
DENN
$119K 0.01%
29,103
– –
MGX icon
560
Metagenomi Therapeutics
MGX
$45.6M
$118K 0.01%
+80,000
New +$125K
CVRX icon
561
CVRx
CVRX
$126M
$118K 0.01%
20,000
-15,000
-43% -$103K
NMRA icon
562
Neumora Therapeutics
NMRA
$276M
$117K 0.01%
+160,000
New +$121K
STRO icon
563
Sutro Biopharma
STRO
$379M
$114K 0.01%
+16,000
New +$131K
PEPG icon
564
PepGen
PEPG
$133M
$111K 0.01%
+100,000
New +$141K
AVIR icon
565
Atea Pharmaceuticals
AVIR
$379M
$108K 0.01%
30,000
-14,929
-33% -$44.5K
DBI icon
566
Designer Brands
DBI
$277M
$108K 0.01%
45,195
– –
MIND icon
567
MIND Technology
MIND
$50.4M
$103K ﹤0.01%
12,238
– –
ENZ
568
DELISTED
Enzo Biochem, Inc.
ENZ
$102K ﹤0.01%
150,000
-100,359
-40% -$32.4K
CRBU icon
569
Caribou Biosciences
CRBU
$156M
$101K ﹤0.01%
+80,000
New +$78.7K
OMCC
570
DELISTED
Old Market Capital Corp
OMCC
$98.9K ﹤0.01%
17,988
– –
MNDO icon
571
Mind CTI
MNDO
$20.6M
$98.8K ﹤0.01%
72,108
– –
RLMD icon
572
Relmada Therapeutics
RLMD
$544M
$98K ﹤0.01%
163,261
– –
ORMP icon
573
Oramed Pharmaceuticals
ORMP
$165M
$96.6K ﹤0.01%
42,947
– –
SGRP
574
DELISTED
SPAR Group
SGRP
$96K ﹤0.01%
100,000
– –
AIRG icon
575
Airgain
AIRG
$74.3M
$94.9K ﹤0.01%
22,700
– –
21 22
23
24 25

Similar funds

TIA
Tandem Investment Advisors Charleston, South Carolina $2.04B AUM 7.97% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.03B AUM 26.86% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
LI
Leeward Investments Boston, Massachusetts $2.03B AUM 32.21% 1-Year Est. Return

RBF Capital's Q2 2025 Portfolio in Review

As of Q2 2025, RBF Capital held 635 positions worth $2.1B, up 26% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

RBF Capital deployed $270M of net new capital in Q2 2025, opening 60 new positions and adding to 34 existing holdings. Its largest new stake was Morgan Stanley: 810,432 shares worth $114M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total International Stock ETF, an estimated $5.52M trimmed.

  • RBF Capital's largest Q2 2025 buy was Morgan Stanley: 810,432 shares worth $114M.
  • RBF Capital added most to Vestis in Q2 2025, an estimated $4.23M increase.
  • RBF Capital's biggest Q2 2025 reduction was Vanguard Total International Stock ETF, cutting an estimated $5.52M.
  • RBF Capital fully exited Despegar.com in Q2 2025, selling an estimated $8.85M.
  • RBF Capital's ten largest holdings make up 26% of its $2.1B portfolio in Q2 2025.
  • RBF Capital opened 60 new positions and closed 33 in Q2 2025.
  • RBF Capital's portfolio value rose 26% quarter-over-quarter to $2.1B.

Based on RBF Capital's 13F filing for Q2 2025, filed 14 Aug 2025.